Meeting Report: Third International Congress of the International Society of Uterus Transplantation, Tübingen.
Journal
Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144
Informations de publication
Date de publication:
01 12 2022
01 12 2022
Historique:
entrez:
27
11
2022
pubmed:
28
11
2022
medline:
30
11
2022
Statut:
ppublish
Résumé
Uterus transplantation (UTx) is currently the only available treatment for absolute uterine factor infertility. The International Society of Uterus Transplantation (ISUTx) was formally founded in 2017 and joined the Transplantation Society as a formal section in 2021. The Third International Congress of the ISUTx was held in Tübingen, Germany, in October 2021, as a hybrid meeting, attended virtually by about 450 delegates and in person by 35 delegates. This report summarizes the Tübingen meeting and complementary topics of relevance presented at the Second ISUTx state-of-the-art webinar meeting, held in Prague, in October 2020. Main topics covered included surgical considerations, including dissection of veins in living donors and the pros and cons of minimally invasive surgery; managing immune risks; UTx during the COVID-19 pandemic; lessons learnt in the areas of imaging and cytomegalovirus infection; long-term psychological outcomes; opportunities to increase organ availability; and new horizons in UTx, including potential reuse of transplants and the utilization of robotic approaches. Implementation of an International UTx Registry was discussed and considered crucial to assure quality, safety, and further progress in UTx. Attempts made thus far have been promising.
Identifiants
pubmed: 36436097
doi: 10.1097/TP.0000000000004188
pii: 00007890-202212000-00004
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2271-2274Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no funding or conflicts of interest.
Références
Brännström M, Johannesson L, Dahm-Kähler P, et al. First clinical uterus transplantation trial: a six-month report. Fertil Steril. 2014;101:1228–1236.
Brännström M, Johannesson L, Bokström H, et al. Livebirth after uterus transplantation. Lancet. 2015;385:607–616.
Brännström M, Belfort MA, Ayoubi JM. Uterus transplantation worldwide: clinical activities and outcomes. Curr Opin Organ Transplant. 2021;26:616–626.
Flyckt R, Farrell R, Falcone T, et al. Meeting report: Second World Congress of the International Society of Uterus Transplantation, Cleveland. Transplantation. 2020;104:1312–1315.
Tummers P, Göker M, Dahm-Kahler P, et al. Meeting report: first state-of-the-art meeting on uterus transplantation. Transplantation. 2019;103:455–458.
Brucker SY, Strowitzki T, Taran FA, et al. Living-donor uterus transplantation: pre-, intra-, and postoperative parameters relevant to surgical success, pregnancy, and obstetrics with live births. J Clin Med. 2020;9:E2485.
Kölle A, Taran FA, Rall K, et al. Neovagina creation methods and their potential impact on subsequent uterus transplantation: a review. BJOG. 2019;126:1328–1335.
Leonhardt H, Thilander-Klang A, Båth J, et al. Imaging evaluation of uterine arteries in potential living donors for uterus transplantation: a comparative study of MRA, CTA, and DSA. Eur Radiol. 2022;32:2360–2371.
Rosenzweig M, Wall A, Spak CW, et al. Pregnancy after CMV infection following uterus transplantation: a case report from the dallas uterus transplant study. Transpl Infect Dis. 2021;23:e13653.